Drug companies look to profit from DSM-5

von freakoutcrazy

The changes to the DSM-5, the updated manual of psychiatric illnesses released earlier this month, include 15 new mental disorders. Psychiatrists and consumer advocates hope that the new range of diagnoses will help more people find treatment for their suffering. But drug companies could also see a benefit: It’s likely that the changes will expand the demand for prescription medications that could treat these conditions.

MORE

Advertisements